Literature DB >> 17179979

The association between body size, prostate volume and prostate-specific antigen.

J H Fowke1, S S Motley, M S Cookson, R Concepcion, S S Chang, M L Wills, J A Smith.   

Abstract

Increasing prostate volume contributes to urinary tract symptoms and may obscure prostate cancer detection. We investigated the association between obesity and prostate volume, prostate-specific antigen (PSA) and PSA density among 753 men referred for prostate biopsy. Among men with a negative biopsy, prostate volume significantly increased approximately 25% from the lowest to highest body mass index (BMI), waist or hip circumference or height categories. PSA was 0.7 ng/ml lower with a high waist-to-hip ratio. These associations were less consistent among subjects diagnosed with high-grade prostatic intraepithelial neoplasia or cancer. Our data suggest that obesity and height are independently associated with prostate volume..

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17179979     DOI: 10.1038/sj.pcan.4500924

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  24 in total

1.  Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume.

Authors:  Jay H Fowke; Sharon Phillips; Tatsuki Koyama; Susan Byerly; Raoul Concepcion; Saundra S Motley; Peter E Clark
Journal:  BJU Int       Date:  2012-06-22       Impact factor: 5.588

Review 2.  PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.

Authors:  Ming Jiang; Douglas W Strand; Omar E Franco; Peter E Clark; Simon W Hayward
Journal:  Differentiation       Date:  2011-06-08       Impact factor: 3.880

3.  Body mass index and serum lipid profile influence serum prostate-specific antigen in Chinese men younger than 50 years of age.

Authors:  Ming Liu; Jian-Ye Wang; Ling Zhu; Gang Wan
Journal:  Asian J Androl       Date:  2010-12-20       Impact factor: 3.285

4.  The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer.

Authors:  Jay H Fowke; Saundra S Motley; Daniel A Barocas; Michael S Cookson; Raoul Concepcion; Susan Byerly; Joseph A Smith
Journal:  Cancer Causes Control       Date:  2010-12-19       Impact factor: 2.506

5.  PSA and body composition by dual X-ray absorptiometry (DXA) in NHANES.

Authors:  Jay H Fowke; Charles E Matthews
Journal:  Prostate       Date:  2010-02-01       Impact factor: 4.104

6.  The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy.

Authors:  Lionel L Bañez; Simone Albisinni; Stephen J Freedland; Andrea Tubaro; Cosimo De Nunzio
Journal:  World J Urol       Date:  2012-07-31       Impact factor: 4.226

7.  Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size.

Authors:  Jay H Fowke; Saundra Motley; Qi Dai; Raoul Concepcion; Daniel A Barocas
Journal:  Cancer Lett       Date:  2012-10-16       Impact factor: 8.679

8.  Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis.

Authors:  Luisa Zuccolo; Ross Harris; David Gunnell; Steven Oliver; Jane Athene Lane; Michael Davis; Jenny Donovan; David Neal; Freddie Hamdy; Rebecca Beynon; Jelena Savovic; Richard Michael Martin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

9.  Association between percent-free prostate-specific antigen and glomerular filtration rate in transrectal ultrasound-guided biopsy-proven patients with prostate-specific antigen levels ranging from 4 to 10 ng/ml.

Authors:  Jae Heon Kim; Ji Sung Shim; Jae Hyun Bae; Hong Seok Park; Du Geon Moon; Soon-Sun Kwon; Jae Young Park
Journal:  World J Urol       Date:  2013-01-03       Impact factor: 4.226

Review 10.  Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study.

Authors:  Jennifer L Beebe-Dimmer; Gary J Faerber; Hal Morgenstern; David Werny; Kirk Wojno; Bronwen Halstead-Nussloch; Kathleen A Cooney
Journal:  Urology       Date:  2008-03-04       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.